Trelagliptin succinate

SKU: orb1305768

Description

Trelagliptin succinate (SYR-472 succinate) is a long-acting DPP-4 inhibitor developed for type 2 diabetes management. It is used in research to study incretin hormone stabilization and glycemic control in both in vitro enzymatic assays and in vivo diabetic animal models.

Research Area

Protein Biochemistry

Key Properties

• CAS Number: 1029877-94-8
• MW: 475.47
• Purity: 100.00%
• Formula: C₂₂H₂₆FN₅O₆
• SMILES: Cn1c(=O)cc(n(c1=O)Cc1c(ccc(c1)F)C#N)N1CCC[C@H](C1)N.C(CC(=O)O)C(=O)O
• Target: DPP-4,Proteasome
• Solubility: DMSO:55 mg/mL (115.68 mM);10% DMSO+40% PEG300+5% Tween 80+45% Saline:2 mg/mL (4.21 mM)

Bioactivity

• Target IC50:
  DPP4:4 nM

Storage & Handling

• Storage: Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature.
• Expiration Date: 12 months from date of receipt.
• Disclaimer: For research use only

Alternative Names

Diabete, Dipeptidyl Peptidase, DPP, DPP4, DPP-4, Anti-diabetic, inhibit, Inhibitor, mellitus, glycemic, Zafatek, SYR472, SYR-472, SYR472 Succinate, SYR-472 Succinate, SYR-472 succinate, SYR 472, SYR 472 Succinate, Trelagliptin, Trelagliptin succinate, Trelagliptin Succinate

Compound Identifiers

PubChem CID

44183569